Biotechnology in France

Date: February 12, 2015
Pages: 36
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B5880AB2F46EN
Leaflet:

Download PDF Leaflet

Biotechnology in France
INTRODUCTION

Biotechnology in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France biotechnology market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

HIGHLIGHTS
  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The French biotechnology industry had total revenues of $5.8bn in 2014, representing a compound annual growth rate (CAGR) of 5.6% between 2010 and 2014.
  • The medical/healthcare segment was the industry's most lucrative in 2014, with total revenues of $3.6bn, equivalent to 61.3% of the industry's overall value.
  • The performance of the industry is forecast to decelerate, with an anticipated CAGR of 2.1% for the five-year period 2014 - 2019, which is expected to drive the industry to a value of $6.5bn by the end of 2019.
FEATURES
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the biotechnology market in France
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in France
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the France biotechnology market with five year forecasts
  • Macroeconomic indicators provide insight into general trends within the France economy
KEY QUESTIONS ANSWERED
  • What was the size of the France biotechnology market by value in 2014?
  • What will be the size of the France biotechnology market in 2019?
  • What factors are affecting the strength of competition in the France biotechnology market?
  • How has the market performed over the last five years?
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
bioMerieux SA
Merck & Co., Inc.
Onxeo
Transgene S.A.
Macroeconomic Indicators
Country Data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table: France biotechnology industry value: $ billion(e)
Table: France biotechnology industry category segmentation: $ billion, (e)
Table: France biotechnology industry geography segmentation: $ billion, (e)
Table: France biotechnology industry value forecast: $ billion
Table: bioMerieux SA: key facts
Table: bioMerieux SA: key financials ($)
Table: bioMerieux SA: key financials (€)
Table: bioMerieux SA: key financial ratios
Table: Merck & Co., Inc.: key facts
Table: Merck & Co., Inc.: key financials ($)
Table: Merck & Co., Inc.: key financial ratios
Table: Onxeo: key facts
Table: Onxeo: key financials ($)
Table: Onxeo: key financials (€)
Table: Onxeo: key financial ratios
Table: Transgene S.A.: key facts
Table: Transgene S.A.: key financials ($)
Table: Transgene S.A.: key financial ratios
Table: France size of population (million)
Table: France gdp (constant prices, $ billion)
Table: France gdp (current prices, $ billion)
Table: France inflation
Table: France consumer price index (absolute)
Table: France exchange rate

LIST OF FIGURES

Figure: France biotechnology industry value: $ billion(e)
Figure: France biotechnology industry category segmentation: % share, by value, (e)
Figure: France biotechnology industry geography segmentation: % share, by value, (e)
Figure: France biotechnology industry value forecast: $ billion
Figure: Forces driving competition in the biotechnology industry in France,
Figure: Drivers of buyer power in the biotechnology industry in France,
Figure: Drivers of supplier power in the biotechnology industry in France,
Figure: Factors influencing the likelihood of new entrants in the biotechnology industry in France,
Figure: Factors influencing the threat of substitutes in the biotechnology industry in France,
Figure: Drivers of degree of rivalry in the biotechnology industry in France,
Figure: bioMerieux SA: revenues & profitability
Figure: bioMerieux SA: assets & liabilities
Figure: Merck & Co., Inc.: revenues & profitability
Figure: Merck & Co., Inc.: assets & liabilities
Figure: Onxeo: revenues & profitability
Figure: Onxeo: assets & liabilities
Figure: Transgene S.A.: revenues & profitability
Figure: Transgene S.A.: assets & liabilities


Skip to top


Ask Your Question

Biotechnology in France
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: